1. Wagner H, Jordan E, Feil B. Studies on the standardization of mistletoe preparations.
Oncology 1986; 43 (Suppl 1): 16-22. 2. Franz H. Mistletoe lectins and their A and B chains …

Mistletoe (Viscum album L.) continues to be the medical herb prescribed most frequently for
cancer patients in German-speaking countries. Demand for this therapy often comes from …

Since the identification and characterization of mistletoe lectins as pharmacologically active
constituents at the end of the 1980s, research on mistletoe has made substantial advances …

Results 79.2% of the physicians reported to provide unconventional cancer therapies,
especially older and more experienced doctors. Among these, the rate of physician with a …

The reason to introduce mistletoe (Viscum album L.) preparations to so-called alternative
cancer therapy was perceived in its entirety by the spiritual intuition of Rudolf Steiner …

Extracts and preparations from the tree parasitic plant mistletoe (Viscum album L.) have
been used in the treatment of cancer for decades. Numerous preclinical and in vitro studies …

Aqueous extracts of the mistletoe plant (ME) have been used for a long time as
complementary medicine with immunomodulatory effects in tumor therapy. However, the …

Background. Traditional mistletoe therapy in cancer patients involves subcutaneous
applications of Viscum album L. preparations, with doses slowly increasing based on patient …

Because of their cytostatic/apoptotic and immunomodulatory effects mistletoe extracts are
often applied in tumour patients. Recent experimental data suggest that the mistletoe lectins …

Background: Two examples of clinical research with mistletoe extracts were used to
demonstrate essential difficulties in carrying out randomized and placebo-controlled trials …